Trial Profile

A clinical trial of CNTY-813 for treatment of type 1 diabetes mellitus

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 23 Jan 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

23 Jan 2026 New trial record
08 Jan 2026 According to a Century Therapeutics media release, the company anticipates submitting an Investigational New Drug (IND) application for CNTY-813 in 2026, with initial clinical data expected in 2027.
08 Jan 2026 According to a Century Therapeutics media release, company has entered into a securities purchase agreement for initial gross proceeds of approximately 135 million dollar, which will be used to support the clinical development of CNTY-813 as a treatment for type 1 diabetes mellitus.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com